10 Best Asian Stocks To Invest In 2014

October 25, 2013: U.S. markets opened higher Friday morning following good earnings reports Thursday night from some big names. The report on durable goods orders was disappointing�and the consumer sentiment index also fell short of low expectations. The data is weak enough, in fact, virtually to ensure that the Fed won�� slow down its asset purchases next month. That pleases equities��investors.

European, Asian, and Latin American markets all closed mixed today.

Monday�� calendar includes the following scheduled data releases and events (all times Eastern):

9:10 a.m. – Industrial production 10:00 a.m. – Pending home sales index 10:30 a.m. – Dallas Fed manufacturing survey 11:30 a.m. – 3- and 6-month bill auctions 1:00 p.m. – 2-year note auction

Here are the closing bell levels for Friday:

S&P500 1759.77 (+7.70; +0.44%) DJIA 15570.28 (+61.07; +0.39%) NASDAQ 3943.36 (+14.40; +0.37%) 10YR TNOTE 2.506% (+0.15625) Gold $1,352.50 (+2.20; +0.2%), up 2.9% for the week WTI Crude oil $97.85 (+0.74; +0.8%), down 3.2% for the week Euro/Dollar: 1.3806 (+0.0005; +0.04%)

Big Earnings Movers: Amazon.com Inc. (NASDAQ: AMZN) is up 9.5% at $363.67 after last night�� results. Microsoft Corp. (NASDAQ: MSFT) is up 6% at $35.73 on good gains in consumer and device sales. Zynga Inc. (NASDAQ: ZNGA) is up 5.5% at $3.73 on a smaller-than-expected loss. The Procter & Gamble Co. (NYSE: PG) is down 0.8% at $79.98 following inline earnings that encouraged investors to take profits. United Parcel Service Inc. (NYSE: UPS) is up 1.2% at $95.62 after good earnings led to a new 52-week high of $97.00.

Best Dividend Stocks For 2015: Foundation Medicine Inc (FMI)

Foundation Medicine, Inc., incorporated on November 12, 2009, is a commercial-stage company. The Company is focused on fundamentally changing the way patients with cancer are treated. The Company�� platform includes methods and algorithms for analyzing tumor tissue samples across all types of cancer, as well as information aggregation and concise reporting capabilities. Its products provide genomic information about each patient�� individual cancer, enabling physicians to optimize treatments in clinical practice and enabling biopharmaceutical companies to develop targeted oncology therapies more effectively.

FoundationOne, its first clinical product, is, to its knowledge, the only commercially available comprehensive molecular information product designed for use in the routine care of patients with cancer. In addition, the Company is considered a non-contracting provider by commercial third-party payors because it has not entered into specific contracts to provide FoundationOne to their covered patients, and as a result it takes on primary responsibility for obtaining reimbursement on behalf of patients.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%�plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.

• [By Lisa Levin]

  Foundation Medicine (NASDAQ: FMI) shares tumbled 7.58% to reach a new 52-week low of $21.23. Foundation Medicine's trailing-twelve-month profit margin is -147.08%.

10 Best Asian Stocks To Invest In 2014: Isis Pharmaceuticals Inc.(ISIS)

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using antisense drug discovery platform. The company?s antisense drug development programs focus on treating cardiovascular, metabolic, cancer, and severe neurodegenerative diseases. It has commercialized antisense drugs and has 24 drugs in development. Isis Pharmaceuticals, through Regulus Therapeutics Inc., also focuses on the discovery, development, and commercialization of microRNA-based therapeutics. The company has strategic alliances and collaboration agreements primarily with GlaxoSmithKline; Genzyme Corporation; Archemix Corp.; Alnylam Pharmaceuticals, Inc.; Bristol-Myers Squibb; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; and Eli Lilly and Company. Isis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  Aegerion PharmaceuticalsInc. (Nasdaq: AEGR) developed a drug, Juxtapid, for a rare genetic condition called homozygous familial hypercholesterolemia, or HoFH, that can raise a person's cholesterol levels to more than 1,000 mg/dL. A healthful level is considered to be less than 200 mg/dL. The disease largely affects kids, who can die of heart attack by age 2. Most are dead by age 11. When Juxtapid hit the market, it was the only therapy available. ISIS Pharmaceuticals Inc. (Nasdaq: ISIS) would soon join in the competition with its less expensive injectable drug, Kynamro, but Juxtapid had fewer side effects and could be administered orally.

• [By WWW.DAILYFINANCE.COM]
  Records fell on Wall Street Friday as another solid report on housing lifted the market for the second day in a row. There's a three-day weekend coming up -- something that often prompts investor caution -- but the gains were broad-based even though volume was fairly light. The VIX, which measures volatility, fell to its lowest level this year. The Dow Jones industrial average (^DJI) gained 63 points, the Nasdaq composite (^IXIC) rose 31, and the Standard & Poor's 500 index (^GPSC) added 8, topping the record high set last week. The Dow Transportation average also raced to an all-time high, lifted by airline stocks. United (UAL) soared more than 4 percent; Delta (DAL) gained more than 1 percent and Southwest (LUV) gained 2 percent. Southwest is at an all-time high, up 79 percent from a year ago. New home sales bounced back with a better than expected 6.4 percent increase last month. Lennar (LEN) and D.R. Horton (DHI) both rose 4 percent. Pulte (PHM), Beazer (BZH) and Hovnanian (HOV) also solid posted gains. Earnings continue to drive retail stocks. Gap (GPS) edged higher even though net fell. Foot Locker (FL) gained 1½ percent after topping expectations. GameStop (GME) rose 4 percent. Its net rose, helped by the rollout last year of new Xbox and PlayStation consoles. Zumiez (ZUMZ) rose 5½ percent on an earnings beat. But Aeropostale (ARO) tumbled 24 percent. Its loss widened and sales declined. The retailer continues to struggle with teen fashion trends. Also on the earnings front, TiVo (TIVO) rose 2 percent as it swung to a profit from a year ago loss. It also reported an increase in the number of subscribers. Hewlett-Packard (HPQ) rose 6 percent on news the company plans to eliminate up to 16,000 additional workers in an effort to cut costs. And several stocks extended big moves from yesterday. Best Buy (BBY) rose more than 3 percent for the second straight day after earnings beat expectations. Isis Pharmaceuticals (ISIS) jumped
• [By Brian Orelli]

  According to an abstract posted at Forbes, Amgen's PCSK9 inhibitor was able to help some patients with a rare genetic disease that causes extremely high levels of cholesterol. For some patients, the drug, dubbed AMG 145, seems to work as well as Aegerion's (NASDAQ: AEGR  ) Juxtapid�or Kynamro from Isis Pharmaceuticals (NASDAQ: ISIS  ) and Sanofi, without the side effects. In addition to taking some sales from Juxtapid and Kynamro, AMG145 looks poised to treat patients with less severe cholesterol problems given the clean side effect profile.

10 Best Asian Stocks To Invest In 2014: Asanko Gold Inc (AKG)

Asanko Gold Inc., incorporated on September 23, 1999, is a natural resource company engaged in the acquisition and exploration of mineral resources in West Ghana. Its mineral properties are in the exploration and development stage. Its primary property is the Esaase project. The Company is focused on advancing the Esaase Gold Project to commercial production. In addition to its principal project, the Company holds a portfolio of other Ghanaian gold concessions in various stages of exploration. As of February 28, 2014, the Company�� material properties consisted of the Asanko Gold Mine project, the Asumura Property and the Diaso Property, all in West Ghana, Africa. In February 2014, Asanko Gold Inc successfully completed the acquisition of PMI Gold Corporation.

Asanko Gold Mine Property

The Asanko Gold Mine Property is a development stage property located in the Amansi East District of Ghana, approximately 35 kilometers south west of the regional capital Kumasi. The property comprises the Nkran pit, the Adubiaso pit, the Dynamite Hill deposit, the Asuadai deposit, the Abore pit and the Esaase deposit. The Property has gold resources of approximately 7.52 million ounces and gold reserves of approximately 4.81 million ounces.

The Asumura Property

The Asumura Property is without known resources or reserves and the work being done by the Company is exploratory in nature. The Asumura Property is located in the south-western part of Ghana and is divided into two parts by the Bia River. The western part of the property is within the Western Region of Ghana in the Juabeso Bia District and the eastern part is in the Brong Ahafo Region of Ghana. The Asumura Property consists of two exploration concessions: Fosukrom and Asumura, which together equal 279.4 square kilometers.

Advisors' Opinion:

• [By MONEYMORNING]

  As well, Primero Mining (NYSE: PPP) bought Brigus Gold Corp (USA)(NYSE: BRD) for $220 million, and Asanko Gold (NYSEMKT: AKG) is acquiring PMI Gold Corporation (TSE: PMV).

10 Best Asian Stocks To Invest In 2014: H&Q Life Sciences Investors (HQL)

H&Q Life Sciences Investors (the Fund) is a diversified, closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in life science companies (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies) agriculture and environmental management. The Fund invests primarily in securities of public and private companies.

The Fund may invest in venture capital and other restricted securities if these securities would comprise 40% or less of net assets. The Fund may purchase and sell (or write) put or call options on any security in which it is permitted to invest. It may purchase and sell (write) options on stock indices (index options). H&Q Life Sciences Investors��investment advisor is Hambrecht & Quist Capital Management, LLC.

Advisors' Opinion:

• [By Harry Domash, Publisher, DividendDetective and Winning Investing]

  Harry Domash: Yeah, in fact, H&Q Life Sciences, ticker (HQL), is actually a closed-end fund, but it invests entirely in biotech and pharmaceutical companies, and if you look around the world, the investing stocks right now—besides the social media stocks—that's really the one area that has had a lot of recent growth and we expect that to continue.

  I think the closed-end fund, and we'll get into that maybe a little bit later, but closed-end funds are a good way to cover it, when you're talking about a sector like that.

  Johnson & Johnson is an interesting case, because, as you know, Johnson & Johnson is a big company that invests, and that owns a lot of different companies itself in the medical field.

  You know, it owns hundreds of operating companies and it's primarily in the pharmaceuticals, and medical devices, and in consumer products, but Johnson & Johnson was a mismanaged company for a while and they were really underperforming their peers.

  In fact, some of their factories were closed, their pharmaceutical production factories were forcibly closed by the government because they didn't meet standards, but they were taken over by a new CEO a few years ago, two or three years ago, and now things are improving, so Johnson & Johnson is kind of coming from down and out to being a leading company again.

  They've got a lot of products, cancer-type products, and things on the pipeline and it just seems like things are going very well so we have hopes that Johnson & Johnson has reported the last two quarters are the first ones that have really been decent, they really showed growth, and then we expect that to accelerate so we're pretty hot on Johnson & Johnson now.

  Steve Halpern: One particularly interesting portfolio that you maintain that I haven't seen anywhere else is based on closed-end funds that pay monthly dividends&mdash

• [By Nate Pile]

  This recommended fund��ambrecht & Quist Life Sciences Fund (HQL)��as also our top pick last year, and the fund rose 44% in 2013.

  In addition to rising in value, the fund has a dividend policy of paying out 2% of its net asset value of each quarter.

10 Best Asian Stocks To Invest In 2014: Tangoe Inc (TNGO)

Tangoe, Inc. (Tangoe), incorporated on February 9, 2000, is a global provider of communications lifecycle management (CLM), software and services to a range of enterprises, including large and medium-sized businesses and other organizations. CLM encompasses the entire lifecycle of an enterprise's communications assets and services, including planning and sourcing, procurement and provisioning, inventory and usage management, mobile device management (MDM), invoice processing, expense allocation and accounting, and asset decommissioning and disposal. Its on-demand Communications Management Platform is a suite of software designed to manage and optimize the complex processes and expenses associated with this lifecycle for both fixed and mobile communications assets and services. On February 21, 2012, it acquired ttMobiles Limited (ttMobiles), On January 10, 2012, Tangoe acquired Anomalous Networks Inc. On December 19, 2011, it acquired ProfitLine, Inc. (ProfitLine).On March 16, 2011, the Company acquired the telecommunications expense management division of Telwares, Inc. and its subsidiary Vercuity Solutions, Inc. (Telwares). On January 25, 2011, it acquired HCL Expense Management Services Inc. (HCL). On August 8, 2012, the Company acquired the Telecommunications Expense Management Business of Symphony Teleca (TEM Business).

The Company�� solution is implemented worldwide, providing service coverage in over 180 countries and territories in over 125 currencies with support for approximately 1,700 different communications carriers and 1,900 different billing formats. Its user interface is translated into 16 different languages and its solution supports compliance with the requirements of 63 regulatory committees around the world. Its on-demand software organizes disparate billing, ordering, asset and usage data into a format, allowing its customers to access, query and analyze their communications expense and asset profile information. Improved control of the billing process helps enterpri! ses ensure they pay their bills on time, avoiding late payments and associated service interruptions. Its software also provides customers proactive and predictive mobile usage alerts allowing them to avoid mobile bill overages. Its solution allows its customers to manage the financial, legal and reputational risks associated with unauthorized or unintended use of their communications assets and services.

Communications Management Platform

The Company�� customers can engage the Company through its client service group to manage their communications assets and services using a combination of CMP and its client services. The services it offers include help desk, asset procurement and provisioning and carrier dispute resolution. Its Communications Data Management technology processes and normalizes service-provider billing and order-related information for its customers. CMP also integrates with its customers' critical third-party enterprise systems, including enterprise resource planning, accounts payable, general ledger and human resources systems, which enables automated, real-time access to and synchronization with employee, accounting, user access authentication and security policy information.

The Company sells CMP in three standard bundles: Asset Management, Expense Management and Usage Management. The Asset Management bundle of CMP provides asset procurement, provisioning, tracking and disposal capabilities for fixed and mobile communications assets and services. The Asset Management bundle tracks and audits all add, move, change or disconnect service transaction orders and manages all customer assets and services by location, business unit and employee. Its MDM software allows its customers to manage and maintain their mobile inventory with wireless, real-time monitoring and remote update functions. Key capabilities of the Asset Management bundle of CMP include catalog management, procure, provision, track, maintain and dispose.

Catalog Manage! ment incl! ude Customer-configurable catalog of over 51,500 services, devices, features and plans with dynamic access and presentation based on corporate policy and user profile. Procure include capture, validation, approval, submission and tracking of fixed and mobile service and equipment orders. Provision is engaged in establishment of mobile device enterprise connectivity with installation of corporate applications, usage and security policies utilizing wireless provisioning capabilities. Track includes tracking of fixed and mobile assets, including information regarding characteristics, configurations, ownership and operational and connectivity status. Maintain include centralized management of mobile devices enabled through on-device software providing security and usage policy enforcement as well as automated mobile policy and mobile application deployments and updates. Dispose include collection, data cleansing and disposal of mobile devices.

The Expense Management bundle of CMP provides automated processing and services to manage every aspect of the fixed and mobile communications billing function, from receipt to payment. Key capabilities of the Expense Management bundle of CMP include contract management, billing, audit, dispute, allocate, payment and optimize. The Usage Management bundle of CMP provides enterprises with visibility and control over how communications assets and services are being used in fixed and mobile environments through a combination of real-time and historical usage tracking as well as corporate communications and security policy enforcement. The Company�� capabilities of the Usage Management bundle of CMP include secure, policy management, monitor, real-time, compliance, performance and support. The Company offers Real-time Telecommunications Expense Management (rTEM) bundled or as a point solution. Its rTEM solution serves the enterprise, medium and small business and carrier deployment markets.

The Company�� rTEM solution provides businesses and ca! rriers of! all sizes the ability to monitor, report and analyze data, voice, short message service (SMS) and roaming consumption of their mobile devices in real-time. Its rTEM solution utilizes predictive algorithms designed to proactively identify and help prevent costly, unexpected overages from occurring. Its rTEM solution also provides device location monitoring services to help find lost or stolen devices, as well as device geo-fencing features to alert appropriate individuals that an asset is leaving or entering pre-defined geographic tracking areas, providing additional device security tracking. Its rTEM solution supports implementation on smartphones, tablets and machine-to-machine communication devices.

Strategic Consulting and Other Services

The Company offers a set of strategic consulting services that address all areas of CLM for fixed and mobile environments. These services can be contracted separately or in conjunction with CMP. Its strategic consulting services offerings include sourcing, strategic advisory service, bill auditing, inventory optimization, mobile optimization and policy administration. The Company assists its customers with reviewing and negotiating contracts with communications carriers. The Company provides its clients with peer comparison analysis and benchmarking. It works with its customers to identify billing errors and other issues related to usage and contract activity. The Company advises its customers on how to align their current asset and service inventories with their business objectives. The Company aids its customers in aligning their mobile policies, assets, contracts and requirements. It works with its customers to formulate policies concerning the appropriate use of communications assets and services. In addition, the Company helps its customers develop policies regarding risk mitigation, entitlements, cost management, liability models, cost allocation methodologies and positive behavioral management. The Company also offers standard imple! mentation! services, including data conversion, system configuration, process review and corporate system integration, to assist its customers in the setup and deployment of CMP.

The Company competes with Emptoris, Rivermine, MDSL, Symphony SMS, Vodafone, XIGO, AirWatch, BoxTone, Good Technology, MobileIron, Sybase, Zenprise, CSC, Orange, Ariba and PAETEC.

Advisors' Opinion:

• [By Evan Niu, CFA]

  What: Shares of Tangoe (NASDAQ: TNGO  ) have danced higher today, up by 13% at the high, after the company announced a partnership with software giant SAP (NYSE: SAP  ) .

• [By Dan Caplinger]

  Finally, outside the Dow, Tangoe (NASDAQ: TNGO  ) jumped 7% after it entered into a software development cooperation agreement with German giant SAP. The deal will greatly enhance Tangoe's exposure and credibility in the telecom expense management solutions space, while helping SAP broaden its overall offerings to help customers develop and manage their mobile ecosystems.

• [By Lauren Pollock]

  Shares of Tangoe Inc.(TNGO) slipped after the software and services provider issued weak outlook targets for the fourth quarter and trimmed full-year expectations. Tangoe’s stock slid 13% to $16.50 premarket. Investors appeared to ignore the company’s third-quarter results, as profit more than doubled on rising revenue and gross margins.

10 Best Asian Stocks To Invest In 2014: Nexans SA (NEX)

Nexans SA is a French company engaged in the cable industry. It provides copper and fiber-optic cables and cabling systems to the Energy Infrastructure, Industry, Building and Local Area Network (LAN) markets. It operates under three segments: Energy, Telecom and Electrical Wires and has six main product lines: indoor cabling, which includes rugged industrial, fire-performance and standard domestic cables; industrial cabling, which comprises a variety of cables for the automotive, aerospace and defense industries, among others; power network cabling, which offers low, medium and high-voltage cables; telecom network cabling that includes a range of copper and optical fiber cables and associated interconnect solutions and cable maker supply, which includes the provision of conductors and superconductive materials for making cables. The LAN Segment provides cables for business networks and offers integrated solutions combining cables, connectors, administration and security. Advisors' Opinion:

• [By Michael Lewis]

  Bloomberg via Getty Images William 'Bill' Ackman founder and CEO of Pershing Square Capital Management (left) Daniel Loeb, founder and CEO of Third Point: Two activist investors taking big positions in large public companies and demand even bigger changes. Is activist investing a force for good when it comes to shareholders? Recent events, namely the Bill Ackman-J.C. Penney (JCP) debacle, have left investors and analysts tired of the outspoken hedge-funders of the world. There are, of course, plenty of activists whose actions have enhanced not just their funds' portfolios, but those of passive, minority shareholders. They've forced companies to make positive changes -- to restructure, elect new board members, and get back on track toward healthier operations. Then again, others end up like J.C. Penney -- a seemingly lost business, rich with legacy yet left crippled by boardroom drama. That leaves us -- the average consumers and investors -- with a pressing question: Are these megaphoned power players trying to effect change that will benefit all, the company included? Or are they just after results that will juice their own returns? The Age of Activism While many activist investors consider themselves to be molded in the image of a certain Omaha-based super-investor, many of today's hedge fund superstars have taken a very different approach to the craft of identifying mispriced securities. Like the old guard -- raiders like Carl Icahn and Nelson Peltz -- young guns such as Daniel Loeb and Bill Ackman take substantial positions in large public companies and demand change in an approach that is about as far from Warren Buffett's investor behavior as one can get. Their style can be best described as personality-driven activism. The practice is on the rise, too. According to FactSet, 2012 saw 21 activist campaigns in companies with market caps larger than $1 billion. In 2010, the number was 11. In 2003, there were four. While some passive shareholders may

10 Best Asian Stocks To Invest In 2014: Pzena Investment Management Inc (PZN)

Pzena Investment Management, Inc. is a publicly owned investment manager. The firm also provides investment advisory services to funds. It provides its services to individuals, typically high net worth individuals; investment companies; charitable organizations; corporations; state or municipal government entities; pension and profit sharing plans; and pooled investment vehicles. The firm manages separate client-focused equity portfolios. It invests in the public equity markets across the globe. The firm primarily invests in value stocks of large-cap, mid-cap, and small-cap companies. It employs fundamental analysis while making its investments. Pzena Investment Management, Inc. was founded in 1995 and is based in New York, New York.

Advisors' Opinion:

• [By Serena Saitto]

  Officials at another Dell shareholder, Pzena Investment Management Inc. (PZN), which has opposed the buyout, didn�� return calls seeking comment.

• [By Bristol Voss]

  Pzena Investment Management (NYSE: PZN) is an investment manager catering to wealthy families and other institutions. It has the largest market cap at $85.4 million, and its share price, although the highest at about $7, buys the most market cap per dollar of the three. It has a forward P/E of 14 and a dividend yield of 1.7%. For the most recent quarter, revenue grew 5.4% and earnings were flat. Although Pzena's gross profit margin was down from the previous year, it remains a very high 45.2%.